Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eton Pharmaceuticals, Inc. - Common Stock
(NQ:
ETON
)
17.21
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eton Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
February 02, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharma (ETON) Q3 2025 Earnings Transcript
↗
November 09, 2025
Eton Pharma (ETON) Q3 2025 Earnings Transcript
Via
The Motley Fool
ETON PHARMACEUTICALS INC (NASDAQ:ETON) Reports Q3 2025 Revenue Beat and EPS Miss
↗
November 06, 2025
Eton Pharmaceuticals Q3 2025 results: A mixed quarter with a 7.6% revenue beat but a miss on earnings per share.
Via
Chartmill
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
November 06, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
A Look Ahead: Eton Pharmaceuticals's Earnings Forecast
↗
May 12, 2025
Via
Benzinga
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
October 23, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton (ETON) Q2 Revenue Jumps 108%
↗
August 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
August 07, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
July 08, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
June 27, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue
↗
May 29, 2025
Eton Pharma's Khindivi has won FDA approval as a pediatric adrenal insufficiency treatment. It is projected to surge in sales and launch in the U.S. in June 2025.
Via
Benzinga
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
May 28, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts
↗
May 14, 2025
Via
Benzinga
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
May 13, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
May 01, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
April 28, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
Evaluating ETON PHARMACEUTICALS INC (NASDAQ:ETON) using Mark Minervini’s winning stock formula
↗
April 25, 2025
A fundamental and technical analysis of (NASDAQ:ETON): Is ETON PHARMACEUTICALS INC (NASDAQ:ETON) suited for high growth investing?
Via
Chartmill
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
April 01, 2025
Esteve Pharmaceuticals, S.A. will commercialize Increlex in all markets outside the U.S.
From
Eton Pharmaceuticals
Via
GlobeNewswire
5 Analysts Assess Eton Pharmaceuticals: What You Need To Know
↗
March 19, 2025
Via
Benzinga
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
March 18, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Earnings Scheduled For March 18, 2025
↗
March 18, 2025
Via
Benzinga
Eton Pharma Plans FDA Filing For ET-600 Oral Desmopressin Next Month, Eyes 2026 Launch
↗
March 14, 2025
Eton Pharmaceuticals' ET-600 met bioequivalence standards in a study, with an FDA filing planned for April 2025 and a potential launch in early 2026.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 14, 2025
Via
Benzinga
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
March 14, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Rocket Companies, Novo Nordisk And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
March 10, 2025
Via
Benzinga
Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025
March 04, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
March 03, 2025
From
Eton Pharmaceuticals
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
